The Centers for Disease Control and Prevention rescinded a guidance that said people without symptoms shouldn’t be tested for COVID-19, even if they had contact with someone with the illness. CDC staff said the guidance was not written by their scientists and was posted to the agency’s website despite their objections. (The New York Times)
State treasurers asked Gilead to lower the price of remdesivir. Nearly a dozen officials wrote a letter to Gilead CEO asking the company not to take “financial advantage” of the pandemic to pursue “unreasonable profits.” (STAT)
A health communications expert broke down what the U.S. and U.K. did wrong at the beginning of the pandemic. The researcher said a lack of transparency and confusing messages hampered the early response. (STAT)
Moderna is on track to produce 20 million COVID-19 vaccine doses by year’s end. The company said it is maintaining its goal of manufacturing 500 million to 1 billion doses in 2021. (Reuters)
Register to attend MM+M’s upcoming webcast “Maximize Your Marketing Efforts with Partner Alignment.” Speakers will include leaders from Veeva, AbbVie and Crossix discussing how to maximize the impact of your marketing investments. The webcast is on September 24. (MM+M)
